Valuation (52%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -1.09 | N/A |
PEG Ratio (TTM) | 0.02 | N/A |
P/S Ratio (TTM) | 0.23 | N/A |
P/B Ratio (TTM) | 0.34 | N/A |
P/FCF Ratio (TTM) | -0.67 | N/A |
Price to 5YR AVG Earnings Ratio | -4.29 | N/A |
Price to 5YR AVG FCF Ratio | 1.53 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.36% | N/A |
ROE (TTM) | -25.81% | N/A |
Net Profit Margin (TTM) | -20.84% | N/A |
ROIC 5YR AVG | -0.54% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -473.44% | -1,105.19% | -735.41% |
Revenue | -4.76% | -2.76% | -0.64% |
Net Income | -356.18% | -1,269.81% | -827.83% |
Cash Flow | -729.34% | 20.47% | 25.05% |
Health (65%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 29.74 | N/A |
Quick Ratio (TTM) | 29.74 | N/A |
D/E Ratio (TTM) | 0.57 | N/A |
Interest Coverage (TTM) | -2.11 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 0.77 | N/A |
LTL to 5YR AVG FCF | 2.76 | N/A |
Shares Outstanding Growth 5YR AVG | 4.84% | N/A |